Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The New England Journal of Medicine|August 5, 1976
The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFyL H Miller, S J Mason, D F Clyde, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|November 1, 1989
Estimate of anti-Plasmodium falciparum sporozoite activity in humans vaccinated with synthetic circumsporozoite protein (NANP)3J R Davis, J R Murphy, S Baqar, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1990
Continuation of chloroquine-susceptible Plasmodium falciparum parasitemia in volunteers receiving chloroquine therapyJ R Murphy, D F Clyde, D A Herrington, et al.
The American Journal of Tropical Medicine and Hygiene|February 1, 1989
Estimate of Plasmodium falciparum sporozoite content of Anopheles stephensi used to challenge human volunteersJ R Davis, J R Murphy, D F Clyde, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1973
A quinoline methanol (WR 30090) for treatment of acute malariaD C Martin, J D Arnold, D F Clyde, et al.
American Journal of Clinical Pathology|November 1, 1976
A modified leukocyte nitroblue tetrazolium test in acute bacterial infectionR M Miller, J Garbus, A R Schwartz, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1973
A phenanthrene methanol (WR 33063) for treatment of acute malariaJ D Arnold, D C Martin, P E Carson, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1993
Effects of ingested human anti-sporozoite sera on Plasmodium falciparum sporogony in Anopheles stephensiJ R Davis, M S Beier, J C Beier, et al.
Tropical and Geographical Medicine|April 1, 1988
A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccinesD A Herrington, D F Clyde, J R Murphy, et al.
Pageof 3